U.S. License Holder:
EMD Serono
Date of License:
March-25-2004
Last Update:
January-23-2023
FDA-Approved Indications
GONAL-F RFF (follitropin alfa for injection) is indicated for the induction of ovulation and pregnancy in the oligo-anovulatory infertile patient in whom the cause of infertility is functional and not due to primary ovarian failure. GONAL-F RFF is also indicated for the development of multiple follicles in the ovulatory patient participating in an Assisted Reproductive Technology (ART) program.